PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28488390 ↗2017Reported benefit

Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner.

MouseChemical/toxinC57Bl/6MaleInjection; specific route not stated

Model: Concanavalin A and alpha-galactosylceramide-induced acute immune-mediated liver injury

Mesenchymal stem cells reduced concanavalin A and alpha-galactosylceramide-mediated hepatitis, suppressed inflammatory natural killer T cell cytokines and cytotoxicity, and this protection was reversed by inhibition of indoleamine 2,3-dioxygenase or inducible nitric oxide synthase.

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.